Pickleball Injuries May Cost Americans Nearly $400 Million This Year

Pickleball, America’s fastest-growing sport, is taking a toll on players’ wrists, legs and shoulders. And it’s especially popular with injury-prone seniors, which is driving up the cost burden. Pickleball injuries may cost Americans $377 million in health care costs this year, accounting for 5% to 10% of total unexpected medical costs, UBS analysts estimated in a report ...

Read More

NABIP Names Jessica Brooks-Woods as Incoming CEO

The National Association of Benefits and Insurance Professionals (NABIP) proudly announces Jessica Brooks-Woods as its incoming CEO and celebrates the remarkable tenure and service of outgoing CEO Janet Trautwein during the Annual Convention held in New Orleans, LA.

Read More

California Strikes Huge Deal Unlocking Billions For Health Care

Major players in California’s health care field have reached a deal on how they want the state to spend $19 billion in proceeds of a renewed tax on insurance plans plus the federal funds that go with it — a development that followed months of private negotiations between bitter industry rivals, state lawmakers and the governor’s office.

Read More

Employers Seek Guidance On Mental Health Benefits: Survey

Employers give themselves poor marks in terms of providing mental health services to their employees but high scores for supporting initiatives to improve diversity, equity and inclusion among their rank and file, according to a new survey by the Northeast Business Group on Health (NEBGH).

Read More

The DEA Relaxed Online Prescribing Rules During COVID. Now It Wants to Rein Them In.

Federal regulators want most patients to see a health care provider in person before receiving prescriptions for potentially addictive medicines through telehealth — something that hasn’t been required in more than three years. During the covid-19 public health emergency, the Drug Enforcement Administration allowed doctors and other health care providers to prescribe controlled medicine during ...

Read More

PhRMA Joins Legal Battle Over Inflation Reduction Act’s ‘Price-Setting’ Measures

After Merck and Bristol Myers Squibb took shots at the Inflation Reduction Act (IRA) in separate lawsuits, influential trade group Pharmaceutical Research and Manufacturers of America (PhRMA)—plus two other organizations—have stepped up to the plate with their own case. PhRMA, along with the Global Colon Cancer Association and the National Infusion Center Association, claim that ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square